GRAIL (GRAL) nears a binary FDA decision on Galleri; learn key catalysts, MCED upside, cash/financing risks, and what September AdCom may mean—read the full analysis here.

Legend Biotech is transitioning from a capital-intensive biotech to a profitable, CARVYKTI-driven commercial cell therapy company. See why LEGN stock is a Buy.

Alert-Based Execution Model: A retail service methodology that uses real-time data to identify store-level issues and triggers immediate field intervention.

Earnings call Bayer delivered 3% sales growth to EUR 24.3 billion and 3% Core EPS growth to EUR 3.66 in H1 2026, with strong Crop Science margin expansion and new pharma product momentum offsetting ...